138 related articles for article (PubMed ID: 31764222)
1. Challenges in Assessing MYC Rearrangement in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type.
Menguy S; Laharanne E; Prochazkova-Carlotti M; Gros A; Vergier B; Parrens M; Beylot-Barry M; Pham-Ledard A; Merlio JP
Am J Surg Pathol; 2020 Mar; 44(3):424-427. PubMed ID: 31764222
[No Abstract] [Full Text] [Related]
2. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Schrader AMR; Jansen PM; Vermeer MH; Kleiverda JK; Vermaat JSP; Willemze R
Am J Surg Pathol; 2018 Nov; 42(11):1488-1494. PubMed ID: 30113335
[TBL] [Abstract][Full Text] [Related]
3. Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas.
Testo N; Olson LC; Subramaniyam S; Hanson T; Magro CM
Am J Dermatopathol; 2016 Oct; 38(10):769-74. PubMed ID: 27391453
[TBL] [Abstract][Full Text] [Related]
4. IRF4 expression without IRF4 rearrangement is a general feature of primary cutaneous diffuse large B-cell lymphoma, leg type.
Pham-Ledard A; Prochazkova-Carlotti M; Vergier B; Petrella T; Grange F; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 May; 130(5):1470-2. PubMed ID: 20054341
[No Abstract] [Full Text] [Related]
5. An Aggressive Primary Cutaneous Follicle Center Lymphoma With c-MYC Translocation and CDKN2A (9p21) Deletion: A Case Report and Review of the Literature.
Tsang HC; Mathew S; Magro CM
Am J Dermatopathol; 2017 Mar; 39(3):e44-e49. PubMed ID: 27759694
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Menguy S; Prochazkova-Carlotti M; Beylot-Barry M; Saltel F; Vergier B; Merlio JP; Pham-Ledard A
Am J Surg Pathol; 2018 Mar; 42(3):326-334. PubMed ID: 29112015
[TBL] [Abstract][Full Text] [Related]
7. Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma.
Pham-Ledard A; Prochazkova-Carlotti M; Andrique L; Cappellen D; Vergier B; Martinez F; Grange F; Petrella T; Beylot-Barry M; Merlio JP
Mod Pathol; 2014 Mar; 27(3):402-11. PubMed ID: 24030746
[TBL] [Abstract][Full Text] [Related]
8. Indolent clinical behaviour of primary cutaneous diffuse large B-cell lymphoma, leg type, with double MYC and BCL6 gene rearrangement.
Rodríguez-Pinilla SM; Santonja C; Stewart P; Carvajal N; McCafferty N; Manso R; Meizoso T; Caro Gutiérrez MD; Piris MÁ; González de Castro D
Br J Haematol; 2020 Nov; 191(3):e83-e86. PubMed ID: 32780869
[No Abstract] [Full Text] [Related]
9. Genetic aberrations in primary cutaneous large B-cell lymphoma: a fluorescence in situ hybridization study of 25 cases.
Wiesner T; Streubel B; Huber D; Kerl H; Chott A; Cerroni L
Am J Surg Pathol; 2005 May; 29(5):666-73. PubMed ID: 15832092
[TBL] [Abstract][Full Text] [Related]
10. [Diffuse large B-cell lymphoma with concomitant c-MYC and BCL6 gene rearrangements with primary skin involvement: A case report and a review of literature].
Gabeeva NG; Koroleva DA; Belyaeva AV; Chernova NG; Kuzmina LA; Sudarikov AB; Obukhova TN; Kovrigina AM; Zvonkov EE; Savchenko VG
Ter Arkh; 2017; 89(7):85-92. PubMed ID: 28766546
[TBL] [Abstract][Full Text] [Related]
11. CD30 expression and its correlation with MYC rearrangement in de novo diffuse large B-cell lymphoma.
Wang XJ; Seegmiller AC; Reddy NM; Li S
Eur J Haematol; 2016 Jul; 97(1):39-47. PubMed ID: 26340843
[TBL] [Abstract][Full Text] [Related]
12. FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type.
Espinet B; García-Herrera A; Gallardo F; Baró C; Salgado R; Servitje O; Estrach T; Colomo L; Romagosa V; Barranco C; Serrano S; Campo E; Pujol RM; Solé F
Histol Histopathol; 2011 Feb; 26(2):213-21. PubMed ID: 21154235
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous Regression of Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.
Toberer F; Mechtersheimer G; Jaschinski H; Enk A; Hakim-Meibodi L; Haenssle HA
Acta Derm Venereol; 2018 Jun; 98(6):608-609. PubMed ID: 29508000
[No Abstract] [Full Text] [Related]
14. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome.
Tibiletti MG; Martin V; Bernasconi B; Del Curto B; Pecciarini L; Uccella S; Pruneri G; Ponzoni M; Mazzucchelli L; Martinelli G; Ferreri AJ; Pinotti G; Assanelli A; Scandurra M; Doglioni C; Zucca E; Capella C; Bertoni F
Hum Pathol; 2009 May; 40(5):645-52. PubMed ID: 19144384
[TBL] [Abstract][Full Text] [Related]
15. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
[TBL] [Abstract][Full Text] [Related]
16. MYC protein expression is associated with poor prognosis in cutaneous diffuse large B-cell lymphoma.
Kim YJ; Won CH; Chang SE; Choi JH; Lee MW; Lee WJ
Australas J Dermatol; 2018 Aug; 59(3):e240-e242. PubMed ID: 28960232
[No Abstract] [Full Text] [Related]
17. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
Landsburg DJ; Falkiewicz MK; Petrich AM; Chu BA; Behdad A; Li S; Medeiros LJ; Cassaday RD; Reddy NM; Bast MA; Vose JM; Kruczek KR; Smith SE; Patel P; Hernandez-Ilizaliturri F; Karmali R; Rajguru S; Yang DT; Maly JJ; Blum KA; Zhao W; Vanslambrouck C; Nabhan C
Br J Haematol; 2016 Nov; 175(4):631-640. PubMed ID: 27469075
[TBL] [Abstract][Full Text] [Related]
18. [Primary cutaneous diffuse large B-cell lymphoma, leg type: a study of clinicopathology, immunophenotype and gene rearrangement].
Wang T; Jia L; Liao W; Chen L; Chen X; Xiong Y; Hao F; Zhu X; Yang X; Wang L
Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):100-5. PubMed ID: 25916640
[TBL] [Abstract][Full Text] [Related]
19. 9p21 deletion in primary cutaneous large B-cell lymphoma, leg type, may escape detection by standard FISH assays.
Wiesner T; Obenauf AC; Geigl JB; Vallant EM; Speicher MR; Fink-Puches R; Kerl H; Cerroni L
J Invest Dermatol; 2009 Jan; 129(1):238-40. PubMed ID: 18704105
[No Abstract] [Full Text] [Related]
20. Diffuse large B-cell lymphoma with MYC gene rearrangements: Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literature.
de Jonge AV; Roosma TJ; Houtenbos I; Vasmel WL; van de Hem K; de Boer JP; van Maanen T; Lindauer-van der Werf G; Beeker A; Timmers GJ; Schaar CG; Soesan M; Poddighe PJ; de Jong D; Chamuleau ME
Eur J Cancer; 2016 Mar; 55():140-6. PubMed ID: 26820684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
